Health and Healthcare
Health and Healthcare Articles
Zynerba Pharmaceuticals has announced positive results from its midstage epilepsy trial, and yet its shares dropped on Wednesday.
Published:
NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola...
Published:
Last Updated:
Karyopharm rose sharply on news of a royalty agreement that could bring as much as $150 million in new capital to the company, and one analyst sees much higher upside on the heels of the news.
Published:
Aimmune shares dipped on Monday after the FDA's Allergenic Products Advisory Committee voted to support the use of AR101 (Palforzia) in children and teens with peanut allergy.
Published:
Alder Bio shares skyrocketed on Monday after the firm announced that Lundbeck would be acquiring it. The transaction is valued at up to $1.95 billion and is expected to close in the fourth quarter of...
Published:
As the current pack of Democratic candidates has several candidates who are over 70 years old, and President Donald Trump is 73, some experts have addressed the question of how old is too old to be...
Published:
Studies have found that microplastics are in the human food chain. Perhaps most disturbing is one that shows they have been discovered in blood and urine samples of young children.
Published:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published:
Last Updated:
Ardelyx shares dropped on Friday after the firm announced that the FDA has approved its treatment of irritable bowel syndrome with constipation in adults.
Published:
According to the Department of Health and Human Services, most healthy adults should get at least 150 minutes of moderate aerobic exercise or 75 minutes of vigorous aerobic exercise a week. However,...
Published:
SmileDirectClub shares dropped on Thursday after its initial public offering.
Published:
Life science technology company 10X Genomics entered the market with a bang on Thursday in its initial public offering.
Published:
Adverum Bio shares dropped sharply on Thursday after the firm announced data from its Optic Phase 1 clinical trial in wet age-related macular degeneration.
Published:
Last Updated:
The influenza season officially runs from October to as late as May each year. Activity peaks around the end of the year and into January. Doctors and public health care experts say that people...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.